Carpenter Brody A, Pirino Breanne E, Jennings Malcolm C, Samels Shanna B, Shah Krisha S, Maser Joya, Gupta Medha, Barson Jessica R
Department of Neurobiology and Anatomy, Drexel University College of Medicine, Philadelphia, Pennsylvania, USA.
Alcohol Clin Exp Res (Hoboken). 2025 Mar;49(3):539-550. doi: 10.1111/acer.15525. Epub 2025 Jan 2.
Pituitary adenylate cyclase-activating polypeptide (PACAP) has been found to be involved in a wide range of motivated and affective behaviors. While the PACAP-38 isoform is more densely expressed than PACAP-27 in most of the brain, PACAP-27 is more highly expressed in the rodent paraventricular nucleus of the thalamus (PVT), where females also have greater expression than males. Notably, the role of PACAP-27 expression in cells of the PVT has not been explored.
Adult, female Long-Evans rats were injected in the PVT with an adeno-associated virus (AAV) to increase expression of PACAP or a control AAV. They were then investigated for subsequent ethanol drinking and preference; sucrose drinking and preference; or locomotor activity in a novel chamber, behavior in a light-dark box, behavior in a novelty suppression of feeding test, locomotor activity in a familiar activity chamber, and behavior in a forced swim test.
Injection with the PACAP AAV resulted in a specific increase in levels of PACAP-27. Rats injected with the PACAP AAV demonstrated reduced drinking and preference for ethanol under the intermittent-access procedure compared to those injected with the control AAV. In contrast, rats injected with the PACAP AAV showed no significant difference in drinking or preference for sucrose, or in any affective behavior tested, except that they spent less time swimming in the forced swim test.
In light of the low overall level of expression of PACAP-27 in the brain, the ability of PACAP-27 in the PVT to control ethanol drinking, with minimal effects on other motivated or affective behaviors, supports the idea that compounds related to PACAP-27 should be investigated as potential therapeutics for the treatment of alcohol use disorder.
垂体腺苷酸环化酶激活多肽(PACAP)已被发现参与广泛的动机和情感行为。虽然PACAP - 38亚型在大脑大部分区域的表达比PACAP - 27更密集,但PACAP - 27在啮齿动物丘脑室旁核(PVT)中表达更高,且雌性的表达也高于雄性。值得注意的是,PACAP - 27在PVT细胞中的作用尚未得到探索。
将腺相关病毒(AAV)注射到成年雌性Long - Evans大鼠的PVT中,以增加PACAP的表达或注射对照AAV。然后研究它们随后的乙醇饮用和偏好;蔗糖饮用和偏好;或在新环境中的运动活动、明暗箱中的行为、新奇抑制摄食试验中的行为、在熟悉活动箱中的运动活动以及强迫游泳试验中的行为。
注射PACAP AAV导致PACAP - 27水平特异性升高。与注射对照AAV的大鼠相比,注射PACAP AAV的大鼠在间歇性获取程序下乙醇饮用和偏好减少。相比之下,注射PACAP AAV的大鼠在蔗糖饮用或偏好方面,以及在测试的任何情感行为方面均无显著差异,只是它们在强迫游泳试验中的游泳时间减少。
鉴于PACAP - 27在大脑中的总体表达水平较低,PVT中的PACAP - 27能够控制乙醇饮用,而对其他动机或情感行为影响最小,这支持了应研究与PACAP - 27相关的化合物作为治疗酒精使用障碍潜在疗法的观点。